Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

998 Can You Treat Me Now? An Evaluation of Patient-Centered Resources Discussing Fatty Liver Treatment Options

View through CrossRef
INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is an increasingly prevalent liver disorder estimated to occur in up to 46 percent of the U.S. adult population. Management includes optimization of weight, diabetes, dyslipidemia, and vitamin E in selected patients. However, patients may opt to self-treat NAFLD based on internet available information, including therapies such as vitamin E which may be potentially harmful if taken in excess. This study evaluated internet accessible information addressing the treatment choices and management of NAFLD. METHODS: The search terms “fatty liver” identified the first 100 websites in the Google search engine. Exclusion criteria for this study included non-accessible websites, video postings without transcripts, or articles discussing veterinary topics. The remaining websites were classified by target audience: patient or professional. Statistical analysis using a two-tailed Fisher’s Exact Test was performed with a P-value set at <0.05. RESULTS: 88 websites met inclusion criteria with 52 (59.1%) targeting patients and 36 (40.9%) for medical professionals. 71 (80.7%) provided management recommendations, with significantly more patient websites discussing treatment (P = 0.02) compared to professional sites. Patient sites more often discussed lifestyle modifications (P = 0.02) as therapy. There was no significant difference in the discussion of diabetic agents, vitamin E, statins, or bariatric surgery between patient and professional websites. Patient websites preferentially discussed treatment benefits compared to possible side effects (P < 0.0001). Patient-clinician shared decision-making was emphasized on patient websites (57.7%; P < 0.01) and websites focused on management strategies (50.7%; P = 0.01). CONCLUSION: Individuals are increasingly using online resources to obtain information about NAFLD management. While patient websites were more likely to discuss lifestyle modification, patient and professional websites did not specifically focus on other potential intervention. Only half the websites recommended shared decision-making, more often occurring in patient websites and in sites addressing management. Across all sites, the benefits rather than potential risks of NAFLD treatment were more frequently discussed. It is important that online websites addressing NAFLD offer treatment options that are evidence-based, promote safe interventions, and encourage discussion with a provider.
Title: 998 Can You Treat Me Now? An Evaluation of Patient-Centered Resources Discussing Fatty Liver Treatment Options
Description:
INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is an increasingly prevalent liver disorder estimated to occur in up to 46 percent of the U.
S.
adult population.
Management includes optimization of weight, diabetes, dyslipidemia, and vitamin E in selected patients.
However, patients may opt to self-treat NAFLD based on internet available information, including therapies such as vitamin E which may be potentially harmful if taken in excess.
This study evaluated internet accessible information addressing the treatment choices and management of NAFLD.
METHODS: The search terms “fatty liver” identified the first 100 websites in the Google search engine.
Exclusion criteria for this study included non-accessible websites, video postings without transcripts, or articles discussing veterinary topics.
The remaining websites were classified by target audience: patient or professional.
Statistical analysis using a two-tailed Fisher’s Exact Test was performed with a P-value set at <0.
05.
RESULTS: 88 websites met inclusion criteria with 52 (59.
1%) targeting patients and 36 (40.
9%) for medical professionals.
71 (80.
7%) provided management recommendations, with significantly more patient websites discussing treatment (P = 0.
02) compared to professional sites.
Patient sites more often discussed lifestyle modifications (P = 0.
02) as therapy.
There was no significant difference in the discussion of diabetic agents, vitamin E, statins, or bariatric surgery between patient and professional websites.
Patient websites preferentially discussed treatment benefits compared to possible side effects (P < 0.
0001).
Patient-clinician shared decision-making was emphasized on patient websites (57.
7%; P < 0.
01) and websites focused on management strategies (50.
7%; P = 0.
01).
CONCLUSION: Individuals are increasingly using online resources to obtain information about NAFLD management.
While patient websites were more likely to discuss lifestyle modification, patient and professional websites did not specifically focus on other potential intervention.
Only half the websites recommended shared decision-making, more often occurring in patient websites and in sites addressing management.
Across all sites, the benefits rather than potential risks of NAFLD treatment were more frequently discussed.
It is important that online websites addressing NAFLD offer treatment options that are evidence-based, promote safe interventions, and encourage discussion with a provider.

Related Results

[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash Abstract This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Background and Introduction: Non-alcoholic fatty liver disease (NAFLD) has been demonstrated that insulin resistance and metabolic syndrome are associated with non-alcoholic fatty ...
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
Objective: This preliminary investigation aimed to assess the value of two elastography techniques, sound touch elastography (STE) and sound touch quantification (STQ), in measurin...
Correlation between Ultrasound Grading of Diffuse Fatty Liver Changes with Density of Liver Measured by Computed Tomography Scan
Correlation between Ultrasound Grading of Diffuse Fatty Liver Changes with Density of Liver Measured by Computed Tomography Scan
Ultrasound is a good imaging modality for diagnosing and grading fatty liver disease. It is an effective method for quantifying fatty liver alterations since it can be used to esti...
Fatty liver formation in fulminant type 1 diabetes
Fatty liver formation in fulminant type 1 diabetes
SummaryA 32-year-old woman presented with 3days of epigastric pain and was admitted to our hospital (day 3 of disease). We diagnosed acute pancreatitis based on epigastric abdomina...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

Back to Top